MedPath

Ropivacaine vs Magnesium with Ropivacaine in Supraclavicular Brachial plexus block in post operative pain relief.

Phase 1
Conditions
Health Condition 1: M966- Fracture of bone following insertion of orthopedic implant, joint prosthesis, or bone plateHealth Condition 2: M974- Periprosthetic fracture around internal prosthetic elbow jointHealth Condition 3: M973- Periprosthetic fracture around internal prosthetic shoulder joint
Registration Number
CTRI/2024/02/062255
Lead Sponsor
Adibur Rahman
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

ASA 1,2 and 3

Patient with upper limb surgeries willing for Supraclavicular Nerve Blocks

Exclusion Criteria

Allergy to Drug

Patient Refusal to Nerve Block

Contraindications to supraclavicular nerve block and Ropivacaine

Patient unable to express VAS score accurately

BMI greater than 35

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
compare postoperative analgesia of Ropivacaine with or without magnesiumTimepoint: 0hrs 6hr 12 hr and 24hrs post surgery
Secondary Outcome Measures
NameTimeMethod
Onset & duration of action of block <br/ ><br>time to need for rescue analgesiaTimepoint: 0hr 6hrs 12hrs & 24hrs
© Copyright 2025. All Rights Reserved by MedPath